Neurological symptoms and findings in COVID-19: a prospective clinical study.
Neurol Res
; 44(1): 1-6, 2022 Jan.
Article
in English
| MEDLINE | ID: covidwho-1313683
ABSTRACT
OBJECTIVE:
We sought to evaluate neurologic symptoms and findings in patients with COVID-19 infection hospitalized in a ward and intensive care unit (ICU).METHODS:
This study was designed as a prospective study. Hospitalized COVID-19 rRt-PCR positive patients in the ward and ICU were included in the study. A 54-item questionnaire was used to evaluate the patients. Patients were examined within 3 hours of hospitalization.RESULTS:
A total of 379 patients were included in the study. The mean age of the patients was 56.1 ± 17.8. 89 of the patients were in intensive care. At least one general symptom was recorded in 95.5% of patients. The most common neurologic symptoms were myalgia (48.5%), headache (39.6%), anosmia (34.8%), and dysgeusia (34%). Neurological symptoms in ICU patients were higher than in the ward. 53.6% of patients had comorbidities.DISCUSSION:
This study indicated that the prevalence of neurological symptoms was very high in patients with COVID-19. The percentage of neurological symptoms and findings was higher in patients hospitalized in ICU.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Dysgeusia
/
Myalgia
/
Anosmia
/
COVID-19
/
Headache
Type of study:
Cohort study
/
Experimental Studies
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Neurol Res
Year:
2022
Document Type:
Article
Affiliation country:
01616412.2021.1952740
Similar
MEDLINE
...
LILACS
LIS